Fluidigm designs and manufactures instruments based on the Integrated Fluidic Circuit technology and Mass Cytometry. The product range includes well-defined panels, both proteomics and genomics, for studies of cancer, inflammatory diseases, and immunotherapies. They also carry a strong portfolio for customized gene expression, copy number variation, SNP genotyping, targeted resequencing, and more. The products are used in, among others, academic, pharmaceutical, and biotech laboratories. Fluidigm is based in California, USA.